Finalización de la adquisición.
25 de enero de 2024
Microsaic Systems plc
("Microsaic" o la "Compañía")
Finalización de la adquisición.
Capitalised terms in this announcement carry the same meaning as in the Circular
or subsequent announcements, unless the context indicates otherwise
Microsaic Systems plc (AIM: MSYS), the developer of micro-electronic instruments and analytical solutions, announces that, further to the announcement made by the Company on 12 January 2024 (RNS No. 5915Z)1, it has completed the acquisition of the Modern Water assets and the Microtox® water testing business previously owned by DeepVerge plc.
Bob Moore, Acting Executive Chairman, commented:
"This concludes our recent corporate activity to recapitalise Microsaic on an enlarged basis by integrating the Modern Water Microtox® water testing business. We are now in the process of installing the acquired equipment in newly leased and lower cost laboratory space in York, England. We intend to restart sales and manufacture of water testing reagents as soon as reasonably practicable, to meet continuing demand from the installed base of Microtox® users.
Additionally, we remain focused on supplying and servicing to customers operating Microsaic's mass spectrometry units, through our existing outsourced manufacturing partner and a newly appointed outsourced servicing partner. We are committed to supporting existing clients and prospective distribution partners in assessing the ProteinID and PFAS2 units ahead of planned field trials expected in H1 2024, designed to assess their performance in monitoring biomanufacturing of drugs and the detection of 'forever chemicals'."
1 https://www.londonstockexchange.com/news-article/MSYS/acquisition-update-change-of-registered-office/16287737
2 PFAS are Perfluoroalkl and Polyfluoroalkyl synthetic chemicals which have potentially carcinogenic properties and don't naturally break down hence called 'forever chemicals'.
Consultas:
Microsaic Systems plc Bob Moore, Acting Executive Chairman | +44 0 20 3657 0050 via TPI |
|
|
Mercados de capitales de cantante Aubrey Powell / Angus Campbell / Oliver Platts | 44 0 20 7496 3000 |
|
|
Turner Papa Inversiones (TPI) Limited Andy Thacker/James Pope | +44 0 20 3657 0050 |
Acerca de Sistemas Microsaic
Microsaic has over 20 years' experience in microelectronics and development of instrumentation. The Company has a robust and innovative patent portfolio in cutting-edge technology designed and developed for "Industry 4.0" application serving markets in diversified Industries, Human and Environmental Health. Microsaic's system solutions have enabled analytical detection and characterisation at the point-of-need, whether within a conventional laboratory setting, or within a bioprocessing facility for continuous detection of data at multiple steps in the process workflow.
Los productos y soluciones de Microsaic están disponibles comercialmente a través de los mercados globales a través de una red de socios regionales y locales, dirigidos a sus principales aplicaciones de laboratorio, fabricación y punto de necesidad.
RNS puede usar su dirección IP para confirmar el cumplimiento de los términos y condiciones, para analizar cómo interactúa con la información contenida en esta comunicación y para compartir dicho análisis de forma anónima con otros como parte de nuestros servicios comerciales. Para obtener más información sobre cómo RNS y la Bolsa de Valores de Londres utilizan los datos personales que nos proporciona, consulte nuestra Política de privacidad.